[A center in Paris for screening and counselling sickle cell patients and carriers].
Prevention of sickle cell anemia, a severe and painful disease, relies on carrier detection and information, and on prenatal diagnosis with the possibility of medical abortion. Here we report the first results of a medical and welfare program launched in Paris 20 months ago and dedicated to sickle cell carrier screening and information.
Tchernia
Gil
G
Centre d'information et de dépistage de la drépanocytose (CIDD) 15-17 rue Charles Bertheau, 75013 Paris. Gil.Tchernia@paris.fr
Bardakdjian
Josiane
J
Lainé
Agnés
A
Ly
Aïcha
A
Orssaud
Geneviève
G
Larnaudie
Sylvie
S
D000032:Abortion, Therapeutic; D000328:Adult; D000755:Anemia, Sickle Cell / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005602:France / Q000453:epidemiology; D006580:Genetic Carrier Screening; D005817:Genetic Counseling / Q000458:organization & administration*; D005820:Genetic Testing / Q000458:organization & administration*; D006801:Humans; D007231:Infant, Newborn; D007253:Information Centers / Q000458:organization & administration*; D008297:Male; D010297:Paris; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis / Q000235:genetics; D011296:Prenatal Diagnosis; D012805:Sickle Cell Trait / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology; D012959:Socioeconomic Factors